Yale-New Haven Medical Center Urology

Topics

• Bladder and Urothelial Cancer Treatments 468
• Prostate Cancer Diagnosis and Treatment 415
• Cancer Immunotherapy and Biomarkers 407
• Renal cell carcinoma treatment 385
• Prostate Cancer Treatment and Research 364
• Breast Cancer Treatment Studies 361
• Urinary Bladder and Prostate Research 342
• HER2/EGFR in Cancer Research 327
• Acute Myeloid Leukemia Research 300
• Lung Cancer Treatments and Mutations 256
• Lung Cancer Diagnosis and Treatment 231
• Pelvic floor disorders treatments 184

Most cited

1. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

   Annals of oncology : official journal of the European Society for Medical Oncology · 2024 · 832 citations · Lajos Pusztai

2. Gastric cancer.

   Lancet (London, England) · 2025 · 309 citations · Raghav Sundar

3. Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.

   The New England journal of medicine · 2022 · 1,014 citations · Lajos Pusztai

4. PD-L1 as a biomarker of response to immune-checkpoint inhibitors.

   Nature reviews. Clinical oncology · 2021 · 1,282 citations · David Rimm

5. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer.

   Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2024 · 381 citations · Frank Detterbeck

6. Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma.

   The New England journal of medicine · 2021 · 1,024 citations · Daniel Petrylak